Global Clinical Research Is Shifting. Mid-Size CROs Are Becoming the Lifeline for Biotech Innovation

My conversation with Jiri Raska revealed the real challenge in European biotech: not the science, but the lack of integrated execution. Mid-size CROs with deep analytical and clinical expertise are becoming essential partners, bridging gaps and accelerating therapies to patients.